MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

Search

Seres Therapeutics Inc

Closed

SectorHealthcare

9.02 -8.24

Overview

Share price change

24h

Current

Min

8.74

Max

10.03

Key metrics

By Trading Economics

Income

-104M

-16M

EPS

-0.11

Employees

103

EBITDA

35M

-15M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

-39.43% downside

Dividends

By Dow Jones

Next Earnings

7 May 2025

Market Stats

By TradingEconomics

Market Cap

3.3M

Previous open

17.26

Previous close

9.02

Technical Score

By Trading Central

Confidence

Weak Bearish Evidence

Seres Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

6 Jun 2024, 10:30 UTC

Acquisitions, Mergers, Takeovers

Seres Therapeutics Enters Into Memorandum of Understanding for Vowst Asset Sale to Nestlé Health Science

Peer Comparison

Price change

Seres Therapeutics Inc Forecast

Price Target

By TipRanks

-39.43% downside

12 Months Forecast

Average 5.5 USD  -39.43%

High 10 USD

Low 1 USD

Based on 3 Wall Street analysts offering 12 month price targets forSeres Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

3 ratings

2

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

7.2 / 9.239Support & Resistance

Short Term

Weak Bearish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$